MolNFT v1 · #122076 · protein
X-ray crystallographic structure of a high affinity IGF2 antagonist (DOMAIN11 AB5 rhh) based on human IGF2R domain 11
5IEI · Cation-independent mannose-6-phosphate receptor: “X-ray crystallographic structure of a high affinity IGF2 antagonist (DOMAIN11 AB5 rhh) based on human IGF2R…”. X-ray diffraction, 1 ligand (SO4). MolNFT v1 #122076 on GenesisL1: 3D…
- PDB
- 5IEI
- Type
- protein
- Length
- 132 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Cation-independent mannose-6-phosphate receptor
- UniProt
- P11717
- Ligands
- SO4
Structure
x-ray diffraction · 1 distinct chain · 5% helix, 46% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Cation-independent mannose-6-phosphate receptor | protein | 132 | 5% helix, 46% strand | P11717 |
Ligands and binding sites
- SO4 · Sulfate ion · ion · 2 copies · chains A
- EDO · 1,2-ethanediol · additive · 2 copies · chains A
- GOL · Glycerol · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Modifications
Observed in the structure: 4 disulfide (disulfide).
Compared structures
- 5IEI · X-ray crystallographic structure of a high affinity IGF2 antagonist (Domain11 AB5 RHH)… · the same entry in another collection · chain A against A, TM-score 1.00
- P11717 · AlphaFold monomer V2.0 prediction for cation-independent mannose-6-phosphate receptor… · a predicted model of the same protein · chain A against A, TM-score 0.95
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P11717
- Elsewhere: RCSB PDB 5IEI · PDBe 5IEI · UniProt P11717
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.